扫描下面的二维码:

二维码

"丙肝"标签列表

慢性丙肝应答指导的治疗2009-12-08

慢性丙肝不同基因型的治疗2009-12-08

基因1、2型丙肝患者血脂情况对HCV RNA的影响2009-12-08

每日1次Narlaprevir联合PEGINTRONTM(聚乙二醇干扰素 α-2b)/病毒唑治疗初发1型慢性丙肝(CHC): NEXT-1研究中期结果,2a期研究2009-12-07

维生素D联合聚乙二醇干扰素和病毒唑对慢性HCV干扰的有益作用2009-12-07

聚乙二醇干扰素联合病毒唑(按体重)治疗2型或3型丙肝病毒感染的荟萃分析2009-12-07

输血后丙型肝炎肝组织超微结构的相关研究2009-08-17

难治性丙肝人群的鉴定和治疗--EASL2009会议上国际肝病采访Pawlotsky教授2009-05-04

Strengthening Management of HCV in Liver Transplantation2009-02-16

New Insights into Hepatitis C and Hepatocellular Carcinoma2009-02-16

Advances in Hepatitis C Infection2009-02-16

Strengthening Investigation on Insulin Resistance and Chronic Hepatitis C Virus Infection2009-02-14

Focus on the Predictive Role of HCV RNA Monitoring2009-02-14

Could Lymphotropic-HCV Replication Affect the Development and Proliferation Activity of Human naive2009-02-14

What Do We Know about the Difficult-to-Treat Patient with Chronic Hepatitis C Infection ?2009-02-14

Strengthening Investigation on the Role of HCV RNA Monitoring2009-02-14

丙肝治疗中HCV基因型及改善生活方式2009-02-14

HCV感染的基因治疗2009-02-14

丙型病毒性肝炎治疗进展2009-02-14

Impact of HCV genotype and treatment regime2009-02-12

领域标签 >>



设为首页 | 加入收藏 | 网站地图 | 订阅杂志 | 关于我们 | 版权声明 | 联系方式|招贤纳士
国际肝病  版权所有  京ICP备15060708号   (京)-非经营性-2016-0001京公网安备 11010502033341号 2004-2020  www.ihepa.com  ALL Rights  Reserved

增值电信业务经营许可证:京B2-20212326

网站统计